Cargando…
Clinical false positives resulting from recent intravenous immunoglobulin therapy: case report
BACKGROUND: Many clinicians are aware that certain therapies administered to their patients can have downstream consequences in the form of clinical laboratory test interferences. This is particularly true of laboratory tests that depend on, or directly involve the use of, antibody-based methodology...
Autores principales: | Suresh, Janarthanee, Kyle, Barry D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981890/ https://www.ncbi.nlm.nih.gov/pubmed/33743628 http://dx.doi.org/10.1186/s12879-021-05986-z |
Ejemplares similares
-
False-positive hepatitis B test results after intravenous immunoglobulin therapy
por: den Hoed-Krijnen, Anne Wil J, et al.
Publicado: (2019) -
Sustained false-positive results for hepatitis A virus immunoglobulin M: A case report and literature review
por: Tan, Youwen, et al.
Publicado: (2021) -
Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature
por: Koch, C., et al.
Publicado: (2015) -
False-positive troponin elevation due to an immunoglobulin-G-cardiac troponin T complex: a case report
por: Akhtar, Zaki, et al.
Publicado: (2020) -
Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review
por: Flores-Oria, Carlos A, et al.
Publicado: (2021)